Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.

Human pathology - 1 Sept 2015

Jang Min Hye, Kim Hyun Jeong, Kim Eun Joo, Chung Yul Ri, Park So Yeon

Abstract excerpt

Triple-negative breast cancer (TNBC) is a heterogeneous group of disease with a well-known association with epithelial-mesenchymal transition (EMT) and breast cancer stem cell phenotype. Recent studies have shown that TNBC can be classified into 6 subtypes, including basal-like, mesenchymal-like, and mesenchymal stem-like subtypes. However, clinical significance of the EMT in TNBC remains unclear. We analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homeodomain Proteins

Share to Kaplan-Meier Estimate

Share to Neoplastic Stem Cells

Share to Proportional Hazards Models

Share to Triple Negative Breast Neoplasms

Share to Zinc Finger E-box-Binding Homeobox 1

Source

Identifiers

PMID: 26170011
DOI: 10.1016/j.humpath.2015.05.010

Genes

ZEB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.PMID 26170011Read ↗

Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.Semantic proximity Read ↗

Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.Semantic proximity Read ↗

Genome–wide binding of transcription factor ZEB1 in triple‐negative breast cancer cellsSemantic proximity Read ↗

Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.Semantic proximity Read ↗

SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerSemantic proximity Read ↗

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cellsSemantic proximity Read ↗

The role of epithelial&ndash;mesenchymal transition programming in invasion and metastasis: a clinical perspectiveSemantic proximity Read ↗

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast CancerSemantic proximity Read ↗

Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.Semantic proximity Read ↗

Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer MetastasisSemantic proximity Read ↗

Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.Semantic proximity Read ↗

Characteristics and transcriptional regulators of spontaneous epithelial–mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.